An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human Embryos

Ferring

Status: Completed

Conditions: Infertility

Treatments: Drug: menotropin

Study type: Observational

Funder types: Industry

Identifiers

NCT02018159

000102

Details and patient eligibility

About

This post-marketing, multi-center prospective study will be conducted in a open-label, non-interventional setting, for women seeking fertility treatment and will describe morphokinetic de-selection parameters in human embryos.

Enrollment: 738 patients

Sex: Female

Ages: 21 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Age 21-45 years
• In Vitro Fertilisation/Intra Cytoplasmic Sperm Injection treatment in long or short protocol
• Receiving follicle stimulation with Menopur 600/1200 IU

Trial design

738 participants in 1 patient group

Women treated with Menopur

Description:

Women treated with Menopur can participate with more than one cycle. 700 cycles will be enrolled.

Treatment:

Drug: menotropin